Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis

Fig. 3

a Representative images of HE-stained liver samples from rats in each group (200x magnification; the black arrows indicate fatty changes). b MAS scores for the rats in each group were compared via one-way ANOVA followed by the least significant difference (LSD) multiple comparison test. ##P < 0.01 compared with Group N, **P < 0.01 compared with Group M, *P < 0.05 compared with Group M

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X